Long-term lymphocytic leukemia (CLL) is usually a lymphoid malignancy characterised because of the proliferation and accumulation of experienced CD5+ B cells from the blood, bone marrow and lymphoid tissues. The prognosis of CLL needs the presence of ?five x109/L mono - clonal B cells of usual phenotype from the blood.103,104 Both of those trials c